5
IRUS TotalDownloads
Altmetric
Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa
File | Description | Size | Format | |
---|---|---|---|---|
s12916-020-01635-5.pdf | Published version | 3.46 MB | Adobe PDF | View/Open |
Title: | Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa |
Authors: | Cork, MA Wilson, KF Perkins, S Collison, ML Deshpande, A Eaton, JW Earl, L Haeuser, E Justman, JE Kinyoki, DK Mayala, BK Mosser, JF Murray, CJL Nkengasong, JN Piot, P Sartorius, B Schaeffer, LE Serfes, AL Sligar, A Steuben, KM Tanser, FC VanderHeide, JD Yang, M Wabiri, N Hay, SI Dwyer-Lindgren, L |
Item Type: | Journal Article |
Abstract: | Background HIV remains the largest cause of disease burden among men and women of reproductive age in sub-Saharan Africa. Voluntary medical male circumcision (VMMC) reduces the risk of female-to-male transmission of HIV by 50–60%. The World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS (UNAIDS) identified 14 priority countries for VMMC campaigns and set a coverage goal of 80% for men ages 15–49. From 2008 to 2017, over 18 million VMMCs were reported in priority countries. Nonetheless, relatively little is known about local variation in male circumcision (MC) prevalence. Methods We analyzed geo-located MC prevalence data from 109 household surveys using a Bayesian geostatistical modeling framework to estimate adult MC prevalence and the number of circumcised and uncircumcised men aged 15–49 in 38 countries in sub-Saharan Africa at a 5 × 5-km resolution and among first administrative level (typically provinces or states) and second administrative level (typically districts or counties) units. Results We found striking within-country and between-country variation in MC prevalence; most (12 of 14) priority countries had more than a twofold difference between their first administrative level units with the highest and lowest estimated prevalence in 2017. Although estimated national MC prevalence increased in all priority countries with the onset of VMMC campaigns, seven priority countries contained both subnational areas where estimated MC prevalence increased and areas where estimated MC prevalence decreased after the initiation of VMMC campaigns. In 2017, only three priority countries (Ethiopia, Kenya, and Tanzania) were likely to have reached the MC coverage target of 80% at the national level, and no priority country was likely to have reached this goal in all subnational areas. Conclusions Despite MC prevalence increases in all priority countries since the onset of VMMC campaigns in 2008, MC prevalence remains below the 80% coverage target in most subnational areas and is highly variable. These mapped results provide an actionable tool for understanding local needs and informing VMMC interventions for maximum impact in the continued effort towards ending the HIV epidemic in sub-Saharan Africa. |
Issue Date: | 7-Jul-2020 |
Date of Acceptance: | 14-May-2020 |
URI: | http://hdl.handle.net/10044/1/90142 |
DOI: | 10.1186/s12916-020-01635-5 |
ISSN: | 1741-7015 |
Publisher: | BioMed Central |
Journal / Book Title: | BMC Medicine |
Volume: | 18 |
Issue: | 1 |
Copyright Statement: | © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
Sponsor/Funder: | Bill & Melinda Gates Foundation |
Funder's Grant Number: | OPP1190661 |
Keywords: | General & Internal Medicine 11 Medical and Health Sciences |
Publication Status: | Published |
Open Access location: | https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01635-5 |
Article Number: | 189 |
Online Publication Date: | 2020-07-07 |
Appears in Collections: | School of Public Health |
This item is licensed under a Creative Commons License